Drugmakers Merck and Novartis recently updated their 340B contract pharmacy restrictions, modifying what states are exempt from such policies following [...] …
Articles by : Bella Czajkowski, National Correspondent
The Trump administration this week continued to oppose drug industry attempts to unilaterally convert 340B discounts to a rebate model, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Mehmet Oz, President Donald Trump’s (R) nominee to lead the Centers for Medicare & Medicaid Services (CMS), faced persistent questioning—primarily [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Two drugmakers recently notified covered entities of adjustments to their 340B drug ceiling prices and resulting refund eligibility. Sumitomo Pharma [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A federal judge ruled that healthcare conglomerate CVS Health did not violate antitrust laws with its contract pharmacy policies, dismissing [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
As state legislatures ramp up efforts to protect contract pharmacy access, drug industry lawsuits against existing state laws continue to [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A coalition of national and local hospital advocacy groups recently filed briefs in multiple federal lawsuits: One that supports the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Florida providers are concerned that a new state bill, which aims to lower Medicaid prices in the state, could significantly [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
After almost cancelling the vote in a last minute search for support, U.S. House Majority Leader Mike Johnson (R-La.) muscled [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
UK-based drugmaker GlaxoSmithKline (GSK) will reinstate its contract pharmacy restrictions in Kansas next month, making it the fourth drug manufacturer [...] …